Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  SHENZHEN STOCK EXCHANGE  >  Winning Health Technology Group Co Ltd    300253   CNE1000016F5

WINNING HEALTH TECHNOLOGY GROUP CO LTD

(300253)
  Report
No quotes available
-- CNY   --.--%
 SummaryRatingsCalendarCompanyFinancialsConsensusRevisions 
Financials (CNY)
Sales 2019 1 893 M
EBIT 2019 444 M
Net income 2019 413 M
Finance 2019 358 M
Yield 2019 0,17%
Sales 2020 2 517 M
EBIT 2020 569 M
Net income 2020 544 M
Finance 2020 442 M
Yield 2020 0,20%
P/E ratio 2019 62,6x
P/E ratio 2020 47,7x
EV / Sales2019 13,6x
EV / Sales2020 10,2x
Capitalization 26 143 M
More Financials
Company
Winning Health Technology Group Co., Ltd. specializes in the publishing of medical software for hospitals, health care facilities and health professionals. The group primarily develops software dedicated for medical information management. Net sales break down by activity as follows: - sale of... 
More about the company
Surperformance© ratings of Winning Health Technology
Trading Rating : Investor Rating :
More Ratings
Latest news on WINNING HEALTH TECHNOLOGY

- No features available -

More news
News in other languages on WINNING HEALTH TECHNOLOGY

- No features available -

More news
Sector news : Healthcare Facilities & Services - NEC
09:02aHCA HOSPITAL AMERICA : Healtre Posts Higher Earnings in 4Q
DJ
01/26THE PHARMACIST IS OUT : Supermarkets Close Pharmacy Counters
DJ
01/21FRESENIUS : Kabi Sets up Joint Venture With Bio-Techne, Wilson Wolf
DJ
01/17Health Executives Brace for Change In Regulation and Competition -- WSJ
DJ
01/16Health Executives Gear Up for Change at J.P. Morgan Conference
DJ
More sector news : Healthcare Facilities & Services - NEC
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 8
Average target price 14,95  CNY
Last Close Price 15,93  CNY
Spread / Highest target 13,0%
Spread / Average Target -6,15%
Spread / Lowest Target -43,5%
EPS Revisions
Managers
NameTitle
Tao Wang President & Director
Wei Zhou Chairman
Li Wang Chief Financial & Accounting Officer
Mao Jin Secretary, Director & Senior Vice President
Ning Liu Vice Chairman